AIDS Behav 2020 Jan 31
Falling Through the Cracks: Risk Factors for Becoming Lost to HIV Care After Incarceration in a Southern Jail.
Tiruneh YM, Li X, Bovell-Ammon B, Iroh P, Flanigan TP, Montague BT, Rich JD, Nijhawan AE
Using a retrospective cohort analysis of inmates released from Dallas County Jail between January 2011 and November 2013, this study characterizes peo ...
Read More
Source: PubMed
AIDS Res Ther
Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda.
Ayitewala A, Kyeyune F, Ainembabazi P, Nabulime E, Kato CD, Nankya I
Resistance to antiretroviral drugs is a major challenge among Human Immunodeficiency Virus (HIV) positive patients receiving antiretroviral therapy (A ...
Read More
Source: PubMed
Ther Drug Monit 2020 Jan 29
Therapeutic drug monitoring of HIV antiretroviral drugs in pregnancy: A narrative review.
O'Kelly B, Murtagh Ba R, Lambert JS
To date, therapeutic drug monitoring (TDM) has played an important role in the management of pregnant HIV patients on highly active antiretroviral the ...
Read More
Source: PubMed
AIDS 2020 Jan 30
Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events.
Gianella S, Moser C, Vitomirov A, McKhann A, Layman L, Scott B, Caballero G, Lada S, Bosch RJ, Hoenigl M, Lurain N, Landay A, Lederman MM, Hunt PW, Smith D
Even with antiretroviral therapy (ART), persons with HIV (PWH) experience increased morbidity/mortality. Cytomegalovirus (CMV) and Epstein-Barr-Virus ...
Read More
Source: PubMed
AIDS 2020 Jan 30
Measuring retention in HIV care: the impact of data sources and definitions using routine data in South Africa.
Phillips TK, Orrell C, Brittain K, Zerbe A, Abrams EJ, Myer L
Measuring retention is critical for antiretroviral therapy (ART) management and program monitoring, however many definitions and data sources, usually ...
Read More
Source: PubMed
